Nanoformulation-based medicines for the treatment of reactive oxygen species-induced diseases: A review. Nanofab [Internet]. 2025 Apr. 14 [cited 2025 Dec. 15];10. Available from: https://eaapublishing.org/journals/index.php/nanofab/article/view/2055